Breaking News Instant updates and real-time market news.

NSP

Insperity

$107.48

1.695 (1.60%)

08:11
11/04/19
11/04
08:11
11/04/19
08:11

Insperity trading halted, news pending

  • 04

    Nov

NSP Insperity
$107.48

1.695 (1.60%)

07/29/19
ROTH
07/29/19
NO CHANGE
ROTH
Insperity earnings selloff today presents buying opportunity, says Roth Capital
Roth Capital analyst Jeff Martin views the post-earnings selloff today in shares of Insperity as a buying opportunity. The company's Q2 results met expectations and management refined annual guidance ranges, with no change to the midpoint of adjusted EBITDA and adjusted earnings, Martin tells investors in a research note. Insperity tempered the expectation for WSEE growth to a midpoint of 14% from 15%, primarily due to net hiring trends within the client base, he adds. The analyst believes today's 20% selloff on the below consensus Q3 guidance is more as a reflection of the "historically-high" valuation than a lack of market conviction in the investment thesis Martin believes the company's fundamentals are still strong. He lowered his price target for the shares to $138 from $147 and maintains a Buy rating on Insperity.
07/30/19
ROTH
07/30/19
NO CHANGE
Target $138
ROTH
Buy
Insperity price target lowered to $138 from $147 at Roth Capital
Roth Capital analyst Jeff Martin lowered his price target for Insperity to $138 from $147 following in-line Q2, but argues that fundamentals are still "strong." The analyst believes the selloff presents opportunity, and reiterates a Buy rating on the shares.
08/15/19
FANA
08/15/19
NO CHANGE
Target $143
FANA
Outperform
Insperity client sentiment as strong as ever, says First Analysis
First analysis analyst James Macdonald kept his Outperform rating and $143 price target on Insperity after holding an investor call with its management. The analyst says the company expressed surprise over the market response to its Q2 results, indicating that client sentiment remains "as strong as ever" with commission levels indicating an economic expansion. Macdonald adds that the lower hiring at Insperity's existing accounts and the large claims do not represent a fundamental problem.
08/21/19
BARD
08/21/19
NO CHANGE
Target $141
BARD
Outperform
Insperity weakness a buying opportunity, says Baird
Baird analyst Mark Marcon spoke with Insperity management regarding WSE growth, direct cost elements, and the potential market opportunity. The analyst said he continues to see plenty of long-term runway for growth given minimal market penetration and increasing employer acceptance for PEO's. Marcon sees the recent selloff as a buying opportunity and he reiterated his Outperform rating and $141 price target on Insperity shares.

TODAY'S FREE FLY STORIES

BIIB

Biogen

$299.29

9.94 (3.44%)

09:14
12/06/19
12/06
09:14
12/06/19
09:14
Recommendations
Biogen analyst commentary  »

Morgan Stanley says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PERI

Perion Network

$5.22

-0.05 (-0.95%)

09:12
12/06/19
12/06
09:12
12/06/19
09:12
Conference/Events
Perion Network management to meet with Lake Street »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

PD

PagerDuty

$24.99

-0.66 (-2.57%)

09:11
12/06/19
12/06
09:11
12/06/19
09:11
Recommendations
PagerDuty analyst commentary  »

PagerDuty price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEBO

Peoples Bancorp

$32.44

0.07 (0.22%)

09:11
12/06/19
12/06
09:11
12/06/19
09:11
Conference/Events
Peoples Bancorp management to meet with DA Davidson »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

ALXN

Alexion

$107.42

-8.07 (-6.99%)

, UBER

Uber

$28.65

-0.405 (-1.39%)

09:09
12/06/19
12/06
09:09
12/06/19
09:09
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Alexion…

ALXN

Alexion

$107.42

-8.07 (-6.99%)

UBER

Uber

$28.65

-0.405 (-1.39%)

TTD

Trade Desk

$240.27

-3.86 (-1.58%)

BIG

Big Lots

$19.17

-0.75 (-3.77%)

GCO

Genesco

$36.94

0.38 (1.04%)

ULTA

Ulta Beauty

$236.09

-3.27 (-1.37%)

DOCU

DocuSign

$69.51

-0.465 (-0.66%)

DOMO

Domo

$19.47

-0.19 (-0.97%)

ZM

Zoom Video

$69.73

-0.22 (-0.31%)

PD

PagerDuty

$24.99

-0.66 (-2.57%)

YEXT

Yext

$16.62

0.065 (0.39%)

CIEN

Ciena

$36.30

-0.3 (-0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 06

    Dec

  • 07

    Dec

  • 09

    Dec

  • 12

    Dec

  • 16

    Dec

  • 16

    Dec

  • 12

    Mar

PARR

Par Pacific

$24.33

0.19 (0.79%)

09:08
12/06/19
12/06
09:08
12/06/19
09:08
Conference/Events
Par Pacific management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

APLE

Apple Hospitality REIT

$15.91

0.02 (0.13%)

09:08
12/06/19
12/06
09:08
12/06/19
09:08
Hot Stocks
Apple Hospitality REIT CFO Rachael Rothman resigns, Bryan Peery succeeds »

Apple Hospitality REIT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGVT

Ingevity

$89.90

-0.02 (-0.02%)

09:06
12/06/19
12/06
09:06
12/06/19
09:06
Downgrade
Ingevity rating change  »

Ingevity downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPRX

OptimizeRx

$8.80

-0.01 (-0.11%)

09:06
12/06/19
12/06
09:06
12/06/19
09:06
Conference/Events
OptimizeRx management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

  • 11

    Dec

ALXN

Alexion

$107.42

-8.07 (-6.99%)

09:06
12/06/19
12/06
09:06
12/06/19
09:06
Hot Stocks
Alexion up 6% after opting not to pursue sale process suggested by activist »

Shares of Alexion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 16

    Dec

S

Sprint

$5.41

-0.265 (-4.67%)

, TMUS

T-Mobile

$76.98

-1.29 (-1.65%)

09:05
12/06/19
12/06
09:05
12/06/19
09:05
Conference/Events
FBN Securities telecom service analysts to hold analyst/industry conference call »

Telecom Services…

S

Sprint

$5.41

-0.265 (-4.67%)

TMUS

T-Mobile

$76.98

-1.29 (-1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 16

    Dec

TYHT

Shineco

$0.75

-0.07 (-8.54%)

09:05
12/06/19
12/06
09:05
12/06/19
09:05
Hot Stocks
Shineco announces completion of first board meeting for 2019 »

Shineco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:05
12/06/19
12/06
09:05
12/06/19
09:05
General news
U.S. equities are making headway »

U.S. equities are making…

PRIM

Primoris

$21.92

0.3 (1.39%)

09:03
12/06/19
12/06
09:03
12/06/19
09:03
Hot Stocks
Primoris announces engineering awards valued over $34M »

Primoris Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$116.51

-2.16 (-1.82%)

09:03
12/06/19
12/06
09:03
12/06/19
09:03
Conference/Events
Neurocrine management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

APVO

Aptevo Therapeutics

$0.60

-0.0395 (-6.18%)

09:02
12/06/19
12/06
09:02
12/06/19
09:02
Hot Stocks
Aptevo Therapeutics receives Orphan Drug Designation for APVO436 »

Aptevo Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPGI

S&P Global

$271.33

2.81 (1.05%)

09:01
12/06/19
12/06
09:01
12/06/19
09:01
Hot Stocks
S&P Global acquires 451 Research, terms not disclosed »

S&P Global announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Jan

CLDR

Cloudera

$10.02

0.16 (1.62%)

09:00
12/06/19
12/06
09:00
12/06/19
09:00
Recommendations
Cloudera analyst commentary  »

Cloudera price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

ORGS

Orgenesis

$2.58

-0.19 (-6.86%)

09:00
12/06/19
12/06
09:00
12/06/19
09:00
Hot Stocks
Orgenesis, Theracell to launch cell therapy platform in HYGEIA Group's network »

Orgenesis announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:00
12/06/19
12/06
09:00
12/06/19
09:00
General news
Treasury Action: yields have jumped on the blowout jobs report »

Treasury Action: yields…

ALXN

Alexion

$107.42

-8.07 (-6.99%)

09:00
12/06/19
12/06
09:00
12/06/19
09:00
Hot Stocks
Breaking Hot Stocks news story on Alexion 

Alexion trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 16

    Dec

ARAY

Accuray

$2.86

0.09 (3.26%)

08:59
12/06/19
12/06
08:59
12/06/19
08:59
Conference/Events
Accuray management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

HAPP

Happiness Biotech

$4.91

(0.00%)

08:59
12/06/19
12/06
08:59
12/06/19
08:59
Initiation
Happiness Biotech initiated  »

Happiness Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EW

Edwards Lifesciences

$242.87

-3.41 (-1.38%)

08:58
12/06/19
12/06
08:58
12/06/19
08:58
Recommendations
Edwards Lifesciences analyst commentary  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COO

Cooper Companies

$313.10

1 (0.32%)

08:57
12/06/19
12/06
08:57
12/06/19
08:57
Recommendations
Cooper Companies analyst commentary  »

Cooper Companies weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.